Therapeutic effect of the immunomodulatory drug lenalidomide, but not pomalidomide, in experimental models of rheumatoid arthritis and inflammatory bowel disease

Thalidomide is an immunomodulatory drug (IMiD) with proven therapeutic action in several autoimmune/inflammatory diseases; however, its inherent high toxicity has led to the development of more powerful and safer thalidomide analogs, including lenalidomide and pomalidomide. These are new generation...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Millan, Belen, Diaz de la Guardia, Rafael, Roca-Ho, Heleia, García-Herrero, Carmen M, Lavoie, Jessie R, Rosu-Myles, Michael, Gonzalez-Rey, Elena, O'Valle, Francisco, Criado, Gabriel, Delgado, Mario, Menendez, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336556/
https://www.ncbi.nlm.nih.gov/pubmed/28154372
http://dx.doi.org/10.1038/emm.2016.143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336556/
https://www.ncbi.nlm.nih.gov/pubmed/28154372
http://dx.doi.org/10.1038/emm.2016.143

Ejemplares similares